Literature DB >> 29687752

Electrocardiographic Evaluation in Patients With Spinal Muscular Atrophy: A Case-Control Study.

Raffaele Falsaperla1, Giovanna Vitaliti1, Ausilia Desiree Collotta1, Chiara Fiorillo2, Alfredo Pulvirenti3, Salvatore Alaimo3, Catia Romano1, Martino Ruggieri4.   

Abstract

BACKGROUND: This study aimed to show the impairment of autonomic cardiac conduction causing bradycardia and/or electrocardiographic alterations in children affected by spinal muscular atrophy type 1 and 2 (SMA 1 and 2).
METHODS: We included 25 spinal muscular atrophy patients, admitted from November 2016 to May 2017. All patients underwent an electrocardiographic examination and we studied PR and QRS intervals, P-waves and QRS amplitudes, and heart rate in spinal muscular atrophy patients compared to a control group.
RESULTS: In all patients, we found longer PRi and QRSi ( P < .05), lower P-wave and QRS complex amplitudes ( P < .01), and a decreased heart rate ( P < .01) with respect to controls. When we divided our patients into SMA1 and SMA2 subgroups, we found that statistical differences were maintained for P-wave and QRS complex amplitudes and heart rate, but not for PRi and QRSi with respect to controls.
CONCLUSION: We suggest the hypothesis of SMN expression on cardiac tissue condition and/or autonomic cardiac conduction.

Entities:  

Keywords:  autonomic cardiac conduction.; bradycardia; electrocardiogram

Mesh:

Year:  2018        PMID: 29687752     DOI: 10.1177/0883073818767170

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy.

Authors:  René Günther; Claudia Diana Wurster; Isabell Cordts; Jan Christoph Koch; Christoph Kamm; Daniel Petzold; Elisa Aust; Marcus Deschauer; Paul Lingor; Albert Christian Ludolph; Andreas Hermann
Journal:  Front Neurol       Date:  2019-11-01       Impact factor: 4.003

2.  SMN-deficiency disrupts SERCA2 expression and intracellular Ca2+ signaling in cardiomyocytes from SMA mice and patient-derived iPSCs.

Authors:  Guzal Khayrullina; Kasey E Moritz; James F Schooley; Naheed Fatima; Coralie Viollet; Nikki M McCormack; Jeremy T Smyth; Martin L Doughty; Clifton L Dalgard; Thomas P Flagg; Barrington G Burnett
Journal:  Skelet Muscle       Date:  2020-05-08       Impact factor: 4.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.